213 related articles for article (PubMed ID: 32597759)
1. CARD14
Manils J; Webb LV; Howes A; Janzen J; Boeing S; Bowcock AM; Ley SC
Elife; 2020 Jun; 9():. PubMed ID: 32597759
[TBL] [Abstract][Full Text] [Related]
2. Gain-of-Function Mutation of Card14 Leads to Spontaneous Psoriasis-like Skin Inflammation through Enhanced Keratinocyte Response to IL-17A.
Wang M; Zhang S; Zheng G; Huang J; Songyang Z; Zhao X; Lin X
Immunity; 2018 Jul; 49(1):66-79.e5. PubMed ID: 29980436
[TBL] [Abstract][Full Text] [Related]
3. Gain of function p.E138A alteration in Card14 leads to psoriasiform skin inflammation and implicates genetic modifiers in disease severity.
Sundberg JP; Pratt CH; Silva KA; Kennedy VE; Qin W; Stearns TM; Frost J; Sundberg BA; Bowcock AM
Exp Mol Pathol; 2019 Oct; 110():104286. PubMed ID: 31323190
[TBL] [Abstract][Full Text] [Related]
4. Psoriasis mutations disrupt CARD14 autoinhibition promoting BCL10-MALT1-dependent NF-κB activation.
Howes A; O'Sullivan PA; Breyer F; Ghose A; Cao L; Krappmann D; Bowcock AM; Ley SC
Biochem J; 2016 Jun; 473(12):1759-68. PubMed ID: 27071417
[TBL] [Abstract][Full Text] [Related]
5. MALT1 targeting suppresses CARD14-induced psoriatic dermatitis in mice.
Van Nuffel E; Staal J; Baudelet G; Haegman M; Driege Y; Hochepied T; Afonina IS; Beyaert R
EMBO Rep; 2020 Jul; 21(7):e49237. PubMed ID: 32343482
[TBL] [Abstract][Full Text] [Related]
6. Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis.
Jordan CT; Cao L; Roberson ED; Duan S; Helms CA; Nair RP; Duffin KC; Stuart PE; Goldgar D; Hayashi G; Olfson EH; Feng BJ; Pullinger CR; Kane JP; Wise CA; Goldbach-Mansky R; Lowes MA; Peddle L; Chandran V; Liao W; Rahman P; Krueger GG; Gladman D; Elder JT; Menter A; Bowcock AM
Am J Hum Genet; 2012 May; 90(5):796-808. PubMed ID: 22521419
[TBL] [Abstract][Full Text] [Related]
7. CARD14 Gain-of-Function Mutation Alone Is Sufficient to Drive IL-23/IL-17-Mediated Psoriasiform Skin Inflammation In Vivo.
Mellett M; Meier B; Mohanan D; Schairer R; Cheng P; Satoh TK; Kiefer B; Ospelt C; Nobbe S; Thome M; Contassot E; French LE
J Invest Dermatol; 2018 Sep; 138(9):2010-2023. PubMed ID: 29689250
[TBL] [Abstract][Full Text] [Related]
8. Essential Role of CARD14 in Murine Experimental Psoriasis.
Tanaka M; Kobiyama K; Honda T; Uchio-Yamada K; Natsume-Kitatani Y; Mizuguchi K; Kabashima K; Ishii KJ
J Immunol; 2018 Jan; 200(1):71-81. PubMed ID: 29150564
[TBL] [Abstract][Full Text] [Related]
9. Intrinsic Abnormalities of Keratinocytes Initiate Skin Inflammation through the IL-23/T17 Axis in a MALT1-Dependent Manner.
Zhang S; Wang M; Wang C; Wang G; Sun K; Xiong S; Cheng L; Yang D; Lin X; Zhao X
J Immunol; 2021 Feb; 206(4):839-848. PubMed ID: 33419765
[TBL] [Abstract][Full Text] [Related]
10. PSORS2 is due to mutations in CARD14.
Jordan CT; Cao L; Roberson ED; Pierson KC; Yang CF; Joyce CE; Ryan C; Duan S; Helms CA; Liu Y; Chen Y; McBride AA; Hwu WL; Wu JY; Chen YT; Menter A; Goldbach-Mansky R; Lowes MA; Bowcock AM
Am J Hum Genet; 2012 May; 90(5):784-95. PubMed ID: 22521418
[TBL] [Abstract][Full Text] [Related]
11. Clinical and Genetic Heterogeneity of
Israel L; Mellett M
Front Immunol; 2018; 9():2239. PubMed ID: 30386326
[TBL] [Abstract][Full Text] [Related]
12. Activating CARD14 Mutations Are Associated with Generalized Pustular Psoriasis but Rarely Account for Familial Recurrence in Psoriasis Vulgaris.
Berki DM; Liu L; Choon SE; David Burden A; Griffiths CEM; Navarini AA; Tan ES; Irvine AD; Ranki A; Ogo T; Petrof G; Mahil SK; Duckworth M; Allen MH; Vito P; Trembath RC; McGrath J; Smith CH; Capon F; Barker JN
J Invest Dermatol; 2015 Dec; 135(12):2964-2970. PubMed ID: 26203641
[TBL] [Abstract][Full Text] [Related]
13. CARD14 alterations in Tunisian patients with psoriasis and further characterization in European cohorts.
Ammar M; Jordan CT; Cao L; Lim E; Bouchlaka Souissi C; Jrad A; Omrane I; Kouidhi S; Zaraa I; Anbunathan H; Mokni M; Doss N; Guttman-Yassky E; El Gaaied AB; Menter A; Bowcock AM
Br J Dermatol; 2016 Feb; 174(2):330-7. PubMed ID: 26358359
[TBL] [Abstract][Full Text] [Related]
14. Common and rare CARD14 gene variants affect the antitumour necrosis factor response among patients with psoriasis.
Coto-Segura P; González-Fernández D; Batalla A; Gómez J; González-Lara L; Queiro R; Alonso B; Iglesias S; Coto E
Br J Dermatol; 2016 Jul; 175(1):134-41. PubMed ID: 26854129
[TBL] [Abstract][Full Text] [Related]
15. CARD14-Mediated Activation of Paracaspase MALT1 in Keratinocytes: Implications for Psoriasis.
Van Nuffel E; Schmitt A; Afonina IS; Schulze-Osthoff K; Beyaert R; Hailfinger S
J Invest Dermatol; 2017 Mar; 137(3):569-575. PubMed ID: 27939769
[TBL] [Abstract][Full Text] [Related]
16. Whole exome sequencing approach to childhood onset familial erythrodermic psoriasis unravels a novel mutation of CARD14 requiring unusual high doses of ustekinumab.
Signa S; Campione E; Rusmini M; Chiesa S; Grossi A; Omenetti A; Caorsi R; Viglizzo GM; Galluzzo M; Bianchi L; Talamonti M; Orlandi A; Martini A; Ceccherini I; Gattorno M
Pediatr Rheumatol Online J; 2019 Jul; 17(1):38. PubMed ID: 31286971
[TBL] [Abstract][Full Text] [Related]
17. CARD14/CARMA2 Signaling and its Role in Inflammatory Skin Disorders.
Zotti T; Polvere I; Voccola S; Vito P; Stilo R
Front Immunol; 2018; 9():2167. PubMed ID: 30319628
[TBL] [Abstract][Full Text] [Related]
18. Regulation and dysregulation of CARD14 signalling and its physiological consequences in inflammatory skin disease.
Mellett M
Cell Immunol; 2020 Aug; 354():104147. PubMed ID: 32593012
[TBL] [Abstract][Full Text] [Related]
19. The genetic background of generalized pustular psoriasis: IL36RN mutations and CARD14 gain-of-function variants.
Sugiura K
J Dermatol Sci; 2014 Jun; 74(3):187-92. PubMed ID: 24656634
[TBL] [Abstract][Full Text] [Related]
20. Autoinflammatory keratinization diseases: An emerging concept encompassing various inflammatory keratinization disorders of the skin.
Akiyama M; Takeichi T; McGrath JA; Sugiura K
J Dermatol Sci; 2018 May; 90(2):105-111. PubMed ID: 29422292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]